Aligos Therapeutics Inc (ALGS)
0.4712
-0.03
(-5.76%)
USD |
NASDAQ |
Jun 17, 16:00
0.4947
+0.02
(+4.99%)
After-Hours: 20:00
Aligos Therapeutics Total Assets (Quarterly): 127.90M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 127.90M |
December 31, 2023 | 151.53M |
September 30, 2023 | 85.85M |
June 30, 2023 | 106.13M |
March 31, 2023 | 121.74M |
December 31, 2022 | 146.69M |
September 30, 2022 | 164.07M |
June 30, 2022 | 182.52M |
March 31, 2022 | 210.47M |
Date | Value |
---|---|
December 31, 2021 | 235.37M |
September 30, 2021 | 263.07M |
June 30, 2021 | 211.88M |
March 31, 2021 | 234.54M |
December 31, 2020 | 265.30M |
September 30, 2020 | 92.18M |
June 30, 2020 | 148.68M |
December 31, 2019 | 146.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.85M
Minimum
Sep 2023
265.30M
Maximum
Dec 2020
170.26M
Average
151.53M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
Mirum Pharmaceuticals Inc | 651.96M |
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 16.19M |
IGC Pharma Inc | 11.26M |
NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 68.11M |
Shareholders Equity (Quarterly) | 59.80M |
Current Ratio | 6.253 |